Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/12/975   
Active ingredient: Carbetocin
Indication: Treatment of Prader-Willi syndrome
Sponsor: Voisin Consulting S.A.R.L.
64 avenue Pierre Grenier, 92100 Boulogne Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2012 Orphan designation EMA/OD/119/11 (2012)2018 of 21/03/2012
5/03/2018 Transfer of orphan designation EMA/OD/119/11/T/01 (2018)1425 of 1/03/2018